Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05466383
Other study ID # GTYN2022001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 24, 2022
Est. completion date December 31, 2026

Study information

Verified date August 2023
Source Shanghai 6th People's Hospital
Contact Chaoyin Jiang, MD
Phone +8689868603821
Email Jiangdoctor1979@sina.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.


Recruitment information / eligibility

Status Recruiting
Enrollment 5000
Est. completion date December 31, 2026
Est. primary completion date December 31, 2026
Accepts healthy volunteers No
Gender All
Age group 9 Years to 16 Years
Eligibility Inclusion Criteria: 1. 9 years = age = 16 years 2. Diagnosis of AIS 3. 10°=Cobb's angle<45° 4. Signed informed consent form Exclusion Criteria: 1. With other developmental disorders, musculoskeletal disorders, nerve disorders, infection disorders, mental disorders, and other disorders 2. Obvious deformity of lower limbs and(or) feet 3. Previous or ongoing treatment of AIS 4. Difficulty to read, understanding, and complete the study questionnaires 5. Any criteria, which, in the opinion of the investigator, suggest that the subject would not be compliant with this study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Exercise
Exercise rehabilitation with Schroth method
Device:
Brace
Wear an orthopedic brace

Locations

Country Name City State
China Haikou orthopedic and diabetes hospital, Haikou orthopedic and diabetes hospital of Shanghai Sixth People's Hospital Haikou Hainan

Sponsors (1)

Lead Sponsor Collaborator
Chaoyin Jiang

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Correlation between the age and the out-of-control rate of treatment Correlation between the patient's age and the out-of-control rate of treatment 36 months
Other Correlation between the BMI at baseline and the out-of-control rate of treatment Correlation between the patient's BMI (kg/m^2) at baseline and the out-of-control rate of treatment 36 months
Other Correlation between the type of AIS and the out-of-control rate of treatment Correlation between the type of AIS and the out-of-control rate of treatment 36 months
Other Correlation between the types of braces and the out-of-control rate of treatment Correlation between the types of braces and the out-of-control rate of treatment 36 months
Other Correlation between the average time spent doing homework per day at baseline and the out-of-control rate of treatment Correlation between the average time (hours) spent doing homework per day at baseline and the out-of-control rate of treatment 36 months
Other Correlation between the vitamin D content at baseline and the out-of-control rate of treatment Correlation between the serum 25(OH)D (nmol/L) at baseline and the out-of-control rate of treatment 36 months
Other Correlation between the average time spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment 36 months
Other Correlation between the age and the change in 36-month Cobb angle from baseline Correlation between the patient's age and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the BMI at baseline and the change in 36-month Cobb angle from baseline Correlation between the patient's BMI (kg/m^2) at baseline and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the type of AIS and the change in 36-month Cobb angle from baseline Correlation between the type of AIS and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the types of braces and the change in 36-month Cobb angle from baseline Correlation between the types of braces and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the average time spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline Correlation between the average time (hours) spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the vitamin D content at baseline and the change in 36-month Cobb angle from baseline Correlation between the serum 25(OH)D (nmol/L) at baseline and the change in 36-month Cobb angle from baseline 36 months
Other Correlation between the average time spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline 36 months
Primary Out-of-control rate of treatment Among the patients with skeletal immaturity (Risser's sign 0, 1, 2), out-of-control rate of treatment at the follow-up to 36 months or at skeletal maturity during the trial (i.e., 4° for female Risser's sign or 5° for male Risser's sign). Out-of-control rate of treatment is defined as either: Cobb angle progression >5°, or Cobb angle =45°, or the physician recommends or already has enhanced the intervention regimen (i.e., no intervention change to exercise intervention, no intervention change to brace intervention, or exercise intervention change to brace intervention). 36 months
Secondary Change in SRS-22 score from baseline over time Change in quality of life (SRS-22 score) from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Secondary Change in vital capacity from baseline over time Change in vital capacity from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment. at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Secondary Change in plantar pressure from baseline over time Change in plantar pressure from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months after treatment compared with those before treatment. at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Secondary Change in gait from baseline over time Change in gait from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Secondary Correlation between the treatment compliance and the out-of-control rate of treatment Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the out-of-control rate of treatment 36 months
Secondary Correlation between the skeletal maturity at baseline and the out-of-control rate of treatment Correlation between the skeletal maturity (Risser's sign) at baseline and the out-of-control rate of treatment 36 months
Secondary Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment 36 months
Secondary Correlation between the immediate correction and the out-of-control rate of treatment Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the out-of-control rate of treatment 36 months
Secondary The incidence of adverse events The incidence of adverse events for the intervention 36 months
Secondary The change in Cobb angle from baseline over time The change in Cobb angle from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment 36 months
Secondary Correlation between the treatment compliance and the change in 36-month Cobb angle from baseline Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the change in 36-month Cobb angle from baseline 36 months
Secondary Correlation between the skeletal maturity at baseline and the change in 36-month Cobb angle from baseline Correlation between the skeletal maturity (Risser's sign) at baseline and the change in 36-month Cobb angle from baseline 36 months
Secondary Correlation between the immediate correction and the change in 36-month Cobb angle from baseline Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the change in 36-month Cobb angle from baseline 36 months
Secondary Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline 36 months
See also
  Status Clinical Trial Phase
Completed NCT05372016 - Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Completed NCT03676101 - Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 1
Recruiting NCT04895020 - Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years Phase 3
Completed NCT04425291 - Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Recruiting NCT05473975 - Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker
Completed NCT05496361 - A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke N/A
Completed NCT02905565 - NBP in Adult Patients With Acute Ischemic Stroke (AIS) Phase 2
Recruiting NCT05152329 - Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers
Terminated NCT05584332 - A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Active, not recruiting NCT06251505 - Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyphosis
Recruiting NCT04422366 - Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females Phase 3
Not yet recruiting NCT03105063 - Evaluation of the AIIS Using Hip Ultrasound(AIISUS) N/A